These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 16864071)
1. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review. Ung YC; Yu E; Falkson C; Haynes AE; Stys-Norman D; Evans WK; Brachytherapy; 2006; 5(3):189-202. PubMed ID: 16864071 [TBL] [Abstract][Full Text] [Related]
2. Out-patient high-dose-rate endobronchial brachytherapy for palliation of lung cancer: an observational study. Scarda A; Confalonieri M; Baghiris C; Binato S; Mazzarotto R; Palamidese A; Zuin R; Fantoni U Monaldi Arch Chest Dis; 2007 Sep; 67(3):128-34. PubMed ID: 18018751 [TBL] [Abstract][Full Text] [Related]
3. High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment. de Aquino Gorayeb MM; Gregório MG; de Oliveira EQ; Aisen S; Carvalho Hde A Brachytherapy; 2013; 12(5):471-8. PubMed ID: 23541114 [TBL] [Abstract][Full Text] [Related]
5. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer. Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184 [TBL] [Abstract][Full Text] [Related]
6. A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience. Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R Brachytherapy; 2015; 14(5):655-61. PubMed ID: 25983031 [TBL] [Abstract][Full Text] [Related]
7. Optimization of dose and fractionation of endobronchial brachytherapy with or without external radiation in the palliative management of non-small cell lung cancer: a prospective randomized study. Mallick I; Sharma SC; Behera D; Ghoshal S; Oinam AS J Cancer Res Ther; 2006; 2(3):119-25. PubMed ID: 17998689 [TBL] [Abstract][Full Text] [Related]
9. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients. Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780 [TBL] [Abstract][Full Text] [Related]
10. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life. Mallick I; Sharma SC; Behera D Lung Cancer; 2007 Mar; 55(3):313-8. PubMed ID: 17157949 [TBL] [Abstract][Full Text] [Related]
11. High-dose-rate brachytherapy for airway malignancy a single institution experience. Siddiqui Z; Falkson C; Hopman W; Mahmud A Brachytherapy; 2023; 22(4):542-546. PubMed ID: 37217415 [TBL] [Abstract][Full Text] [Related]
12. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer]. Makarewicz R Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625 [TBL] [Abstract][Full Text] [Related]
13. Endobronchial brachytherapy for metastasis from extrapulmonary malignancies as an effective treatment for palliation of symptoms. Donovan E; Timotin E; Farrell T; Donde B; Puksa S; Sur R Brachytherapy; 2017; 16(3):630-638. PubMed ID: 28202343 [TBL] [Abstract][Full Text] [Related]
14. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560 [TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy. Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162 [TBL] [Abstract][Full Text] [Related]
16. Salvage treatment with sole high-dose-rate endobronchial interventional radiotherapy (brachytherapy) for isolated endobronchial tumor recurrence in non-small-cell lung cancer patients: a 20-year experience. Soror T; Kovács G; Fürschke V; Ismail M; Badakhshi H Brachytherapy; 2019; 18(5):727-732. PubMed ID: 31227399 [TBL] [Abstract][Full Text] [Related]
17. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer. Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415 [TBL] [Abstract][Full Text] [Related]
18. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Stout R; Barber P; Burt P; Hopwood P; Swindell R; Hodgetts J; Lomax L Radiother Oncol; 2000 Sep; 56(3):323-7. PubMed ID: 10974381 [TBL] [Abstract][Full Text] [Related]
19. A case of radiation bronchitis induced massive hemoptysis after high-dose-rate endobronchial brachytherapy. Lee SJ; Lee JY; Jung SH; Lee SN; Lee JH; Kim CW; Jung S; Jung YR; Lee WY Tuberc Respir Dis (Seoul); 2012 Dec; 73(6):325-30. PubMed ID: 23319995 [TBL] [Abstract][Full Text] [Related]
20. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]